
Immunochromatographic tests for the qualitative detection of Respiratory Syncytial Virus (RSV) and Influenza virus types A and B (in separate bands), as well as SARS-CoV-2 virus (COVID-19) and respiratory Adenovirus from respiratory swabs, washings and nasopharyngeal aspirates.
Respiratory Syncytial Virus (RSV) is the leading cause of emergency department visits and hospitalization for acute lower respiratory tract infections in infants and young children worldwide. In addition, its infective characteristics have made RSV one of the leading causes of nosocomial infection.
Influenza virus is a serious and highly contagious infection of the respiratory tract. Influenza type A viruses are generally more common than type B viruses and are also associated with the most severe influenza epidemics.
Adenovirus is a virus of the Adenoviridae family. The symptoms of Adenovirus infections are similar to a common cold, but unlike other respiratory viruses such as influenza or RSV, it is not seasonal and it can be detected throughout the year.
The SARS-CoV-2 coronavirus (causing COVID-19 disease) is associated with cases of pneumonia with frequent symptoms of dry cough, fever, fatigue or loss of smell, and can easily progress to severe pneumonia, severe acute respiratory syndrome, fatal multi-organ failure and even death.
The rapid identification of these viruses, which in many cases share the same symptoms, is very important as it saves on healthcare costs by reducing both the number of hospitalised patients and the drugs prescribed (if it is confirmed to be a viral infection, antibiotics would not be prescribed). In the case of influenza, not all antiviral drugs are effective against Influenza A virus and Influenza B virus. Hence the importance of distinguishing between the two types.
Results in maximum 15 minutes
Compatible with various samples
Simple and safe
Different formats and combinations adapted to different users
Automated reading
Product
|
Catalogue No.
|
Contents
|
Sample
|
Promotional Sheet
|
CE Decl.
|
Instruct.
|
---|---|---|---|---|---|---|
Simple/Stick RSV
|
9.064.020.15.000
|
Simple 20 tests/kit. Visual or automated reading
|
Nasal/Nasopharyngeal swab - Nasopharyngeal wash/aspirate
|
|||
9.064.020.46.000
|
Simple 20 tests/kit. Visual or automated reading
|
|||||
9.064.020.71.000
|
Simple 20 tests/kit. Visual reading
|
|||||
9.064.020.87.000
|
Simple 20 tests/kit + positive control. Visual or automated reading
|
|||||
Simple/Stick RespirAdeno
|
9.091.020.46.000
|
Simple 20 tests/kit. Visual or automated reading
|
Nasal/Nasopharyngeal swab - Nasopharyngeal wash/aspirate
|
|||
9.091.020.87.000
|
Simple 20 tests/kit + positive control. Visual or automated reading
|
|||||
9.091.020.15.000
|
Stick 20 tests/kit. Visual reading
|
|||||
Simple/Stick Flu A+B
|
9.080.020.46.000
|
Simple 20 tests/kit. Visual or automated reading
|
Nasal/Nasopharyngeal swab - Nasopharyngeal wash/aspirate
|
|||
9.080.020.71.000
|
Simple 20 tests/kit. Visual reading
|
|||||
9.080.020.87.000
|
Simple 20 tests/kit + positive control. Visual or automated reading
|
|||||
9.080.020.15.000
|
Stick 20 tests/kit. Visual reading
|
|||||
Simple/Stick SARS-CoV-2
|
9.233.020.21.000
|
Simple 20 tests/kit. Visual or automated reading
|
Nasal/Oropharyngeal/Nasopharyngeal swab
|
|||
9.233.020.71.000
|
Simple 20 tests/kit. Visual reading
|
|||||
9.233.020.87.000
|
Simple 20 tests/kit + positive control. Visual or automated reading
|
|||||
9.233.020.15.000
|
Stick 20 tests/kit. Visual reading
|
|||||
Simpe RSV-Flu A+B
|
9.081.020.47.000
|
Simple 20 tests/kit. Visual or automated reading
|
Nasal/Nasopharyngeal swab - Nasopharyngeal wash/aspirate
|
|||
9.081.020.71.000
|
Simple 20 tests/kit. Visual reading
|
|||||
9.081.020.87.000
|
Simple 20 tests/kit + positive control. Visual or automated reading
|
|||||
Simple RSV-Respiradeno
|
9.110.020.47.000
|
Simple 20 tests/kit. Visual or automated reading
|
Nasal/Nasopharyngeal swab - Nasopharyngeal wash/aspirate
|
|||
9.110.020.71.000
|
Simple 20 tests/kit. Visual reading
|
|||||
9.110.020.87.000
|
Simple 20 tests/kit + positive control. Visual or automated reading
|
|||||
Simple Ag SARS-CoV-2 / Flu A+B
|
9.242.020.36.000
|
Simple 20 tests/kit. Visual or automated reading
|
Oropharyngeal/Nasopharyngeal swab
|
|||
9.242.020.71.000
|
Simple 20 tests/kit. Visual reading
|
|||||
9.242.020.87.000
|
Simple 20 tests/kit + positive control. Visual or automated reading
|
|||||
Positive control (RSV/Flu/Adenovirus)
|
9.235.011.12.000
|
1 swab/kit
|
N/A
|
N/A
|
||
Positive control (SARS-CoV-2)
|
9.233.011.12.000
|
1 swab/kit
|
N/A
|
N/A
|
Rapid identification and differentiation of RSV, Influenza, SARS-CoV-2 and Respiratory Adenovirus allows for cost savings in healthcare, optimal patient management and the most appropriate diagnosis and treatment.
Products adapted to rapid and urgent point-of-care or PoC diagnostics, with reproducible results in 15 minutes maximum, without the need for volumetric measurements of reagents that are susceptible to error. In addition, they require minimal handling and contact with the sample by the professional performing the test, and come with all components ready for use.
Possibility of automated reading with OPERON immunochromatography strip reader. The interpretation of results on the Simple/Stick RSV, Simple/Stick Flu A+B, Simple/Stick RespirAdeno and Simple/Stick Ag SARS-CoV-2 products, as well as on any of the combos, can be done both visually and automated. This minimises the possibility of error and provides the professional in charge of the execution with the possibility of recording the results obtained.
We have references that include the swabs for sample collection, as well as a positive control so that the user can validate the results obtained. These controls can also be purchased as a separate commercial reference.
N.º
|
Title
|
Link
|
Language
|
---|---|---|---|
1
|
EVALUATION OF A RAPID IMMUNOCHROMATOGRAPHIC POINT OF CARE TEST THAT DETECTS THE RESPIRATORY SYNCYTIAL VIRUS IN HUMAN RESPIRATORY SAMPLES
|
English
|
|
2
|
EVALUATION OF A RAPID IMMUNOCHROMATOGRAPHIC POINT OF CARE TEST THAT DETECTS THE RESPIRATORY SYNCYTIAL VIRUS IN RESPIRATORY SAMPLES (POSTER FORMAT)
|
English
|
|
3
|
The impact of childhood RSV infection on children’s and parents’ quality of life: a prospective multicenter study in Spain
|
English
|
Dr. María Alejandra Torres, haemato-oncologic and member of the Venezuelan COVID Commission, gives an interesting overview of all the diagnostic tools currently available for the detection of COVID-19.
The recorded webinar is available on demand. If you missed it, feel free to request it!
Our RSV, Flu A+B and SARS-CoV-2 detection products use the same dilution buffer. This means that, with a single sample, all three tests could be run and all three viruses could be detected.
All tests are designed for use by healthcare professionals only.
Both the Simple/Stick Ag SARS-CoV-2 test and the Simple Ag SARS-CoV-2/Flu A+B test use monoclonal antibodies specific to the N protein of the SARS-CoV-2 virus and are therefore suitable for detecting the different prevalent variants of the virus.
Indeed, both tests are designed to be as safe as possible for the user. Both tests are designed to be as safe as possible for the professional who performs them, so the diluent contains virus-inactivating detergents.
The tests detect the nucleoprotein of Influenza virus type A and type B, in separate bands.
Influenza type A viruses are generally more frequent than type B viruses, and are associated with the most severe influenza epidemics (especially the H3N2 subtype), while type B infections are usually milder. Within type A, the H1N1 and H3N2 subtypes are the most important in humans.
Influenza A viruses are generally more common than type B viruses. Within type A, the N1N1 subtypes are the most important in humans. The evaluation of the diagnostic sensitivity and specificity of our kit has not been done with samples characterised at subtype level. However, for the determination of the analytical sensitivity of Influenza type A we used a reference standard of the H1N1 subtype, so we can confirm that the Stick/Simple Flu A+B test detects the H1N1 influenza subtype.
The tests detect the F protein, which is responsible for fusion and entry of the virus into the cell. It is present in both subtypes of RSV (types A and B), and in all genotypes into which they are divided.
The tests detect the Adenovirus hexon, which is a highly conserved protein in the various serotypes of the Adenovirus family. Types 3, 4, 7 and 14 are the most commonly associated with respiratory infection.
The tests are compatible with different means of transport, which are indicated in the instructions for use of each product.
In general, we recommend Flocked Swabs from Copan Flock Technologies to ensure optimal test performance. In the Instructions for Use of each product, the swabs that have been evaluated and with which the best results are obtained are indicated. In addition, we have some references that include swabs.